Clinical Trials A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis® by ClinicalTrialsFeed • 2015/03/17 • 0 Comments Status: Withdrawn, Condition Summary: Dry Eye Disease Full Story →